- Home
- BWLP vs IMCR Comparison
BWLP vs IMCR Comparison
Compare BWLP & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- IMCR
- Stock Information
- Founded
- BWLP 1935
- IMCR 2008
- Country
- BWLP Singapore
- IMCR United Kingdom
- Employees
- BWLP N/A
- IMCR N/A
- Industry
- BWLP Marine Transportation
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWLP Consumer Discretionary
- IMCR Health Care
- Exchange
- BWLP Nasdaq
- IMCR Nasdaq
- Market Cap
- BWLP 1.6B
- IMCR 1.5B
- IPO Year
- BWLP N/A
- IMCR 2021
- Fundamental
- Price
- BWLP $12.36
- IMCR $32.75
- Analyst Decision
- BWLP
- IMCR Buy
- Analyst Count
- BWLP 0
- IMCR 10
- Target Price
- BWLP N/A
- IMCR $58.13
- AVG Volume (30 Days)
- BWLP 426.6K
- IMCR 439.6K
- Earning Date
- BWLP 08-27-2025
- IMCR 08-07-2025
- Dividend Yield
- BWLP 13.80%
- IMCR N/A
- EPS Growth
- BWLP N/A
- IMCR N/A
- EPS
- BWLP 1.86
- IMCR N/A
- Revenue
- BWLP $3,387,328,000.00
- IMCR $333,581,000.00
- Revenue This Year
- BWLP N/A
- IMCR $26.82
- Revenue Next Year
- BWLP $2.04
- IMCR $8.15
- P/E Ratio
- BWLP $7.13
- IMCR N/A
- Revenue Growth
- BWLP 9.53
- IMCR 25.75
- 52 Week Low
- BWLP $7.86
- IMCR $23.15
- 52 Week High
- BWLP $19.36
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- BWLP 64.10
- IMCR 49.96
- Support Level
- BWLP $11.58
- IMCR $30.76
- Resistance Level
- BWLP $12.18
- IMCR $32.55
- Average True Range (ATR)
- BWLP 0.31
- IMCR 1.49
- MACD
- BWLP -0.01
- IMCR -0.25
- Stochastic Oscillator
- BWLP 87.11
- IMCR 32.68
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.